An Androgen Receptor NH2-terminal Conserved Motif Interacts with the COOH Terminus of the Hsp70-interacting Protein (CHIP)*

The NH2-terminal sequence of steroid receptors is highly variable between different receptors and in the same receptor from different species. In this study, a primary sequence homology comparison identified a 14-amino acid NH2-terminal motif of the human androgen receptor (AR) that is common to AR from all species reported, including the lower vertebrates. The evolutionarily conserved motif is unique to AR, with the exception of a partial sequence in the glucocorticoid receptor of higher species. The presence of the conserved motif in AR and the glucocorticoid receptor and its absence in other steroid receptors suggests convergent evolution. The function of the AR NH2-terminal conserved motif was suggested from a yeast two-hybrid screen that identified the COOH terminus of the Hsp70-interacting protein (CHIP) as a binding partner. We found that CHIP functions as a negative regulator of AR transcriptional activity by promoting AR degradation. In support of this, two mutations in the AR NH2-terminal conserved motif previously identified in the transgenic adenocarcinoma of mouse prostate model reduced the interaction between CHIP and AR. Our results suggest that the AR NH2-terminal domain contains an evolutionarily conserved motif that functions to limit AR transcriptional activity. Moreover, we demonstrate that the combination of comparative sequence alignment and yeast two-hybrid screening using short conserved peptides as bait provides an effective strategy to probe the structure-function relationships of steroid receptor NH2-terminal domains and other intrinsically unstructured transcriptional regulatory proteins.

[1]  M. Mayer,et al.  Dimerization of the Human E3 Ligase CHIP via a Coiled-coil Domain Is Essential for Its Activity* , 2004, Journal of Biological Chemistry.

[2]  Desok Kim,et al.  The Androgen Axis in Recurrent Prostate Cancer , 2004, Clinical Cancer Research.

[3]  R. Vessella,et al.  Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.

[4]  W. Sessa,et al.  Chaperone-dependent Regulation of Endothelial Nitric-oxide Synthase Intracellular Trafficking by the Co-chaperone/Ubiquitin Ligase CHIP* , 2003, Journal of Biological Chemistry.

[5]  I. McEwan,et al.  Role of conserved hydrophobic amino acids in androgen receptor AF-1 function. , 2003, Journal of molecular endocrinology.

[6]  V. Godfrey,et al.  CHIP activates HSF1 and confers protection against apoptosis and cellular stress , 2003, The EMBO journal.

[7]  David Crews,et al.  Resurrecting the Ancestral Steroid Receptor: Ancient Origin of Estrogen Signaling , 2003, Science.

[8]  H. Kampinga,et al.  Overexpression of the Cochaperone CHIP Enhances Hsp70-Dependent Folding Activity in Mammalian Cells , 2003, Molecular and Cellular Biology.

[9]  S. Yeh,et al.  The Use of Phage Display Technique for the Isolation of Androgen Receptor Interacting Peptides with (F/W)XXL(F/W) and FXXLY New Signature Motifs* , 2003, Journal of Biological Chemistry.

[10]  E. Wilson,et al.  Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs , 2003, Molecular and Cellular Biology.

[11]  C. Patterson,et al.  C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation. , 2003, Archives of biochemistry and biophysics.

[12]  I. McEwan,et al.  The Androgen Receptor Interacts with Multiple Regions of the Large Subunit of General Transcription Factor TFIIF* , 2002, The Journal of Biological Chemistry.

[13]  L. Neckers,et al.  Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Shabanowitz,et al.  Androgen Receptor Phosphorylation , 2002, The Journal of Biological Chemistry.

[15]  S. Wing,et al.  Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity. , 2002, Journal of molecular endocrinology.

[16]  E. Wilson,et al.  Dependence of Selective Gene Activation on the Androgen Receptor NH2- and COOH-terminal Interaction* , 2002, The Journal of Biological Chemistry.

[17]  D. Cyr,et al.  Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. , 2002, Trends in biochemical sciences.

[18]  N. C. Price,et al.  Conformational Analysis of the Androgen Receptor Amino-terminal Domain Involved in Transactivation , 2002, The Journal of Biological Chemistry.

[19]  F. Hartl,et al.  Ligand Discrimination by TPR Domains , 2002, The Journal of Biological Chemistry.

[20]  A. Citri,et al.  Drug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy , 2002, The EMBO journal.

[21]  E. Wilson,et al.  The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators* , 2002, The Journal of Biological Chemistry.

[22]  H. Erdjument-Bromage,et al.  Identification and Functional Characterization of the p66/p68 Components of the MeCP1 Complex , 2022 .

[23]  D. Toft,et al.  Effect of geldanamycin on androgen receptor function and stability , 2002, Cell stress & chaperones.

[24]  Keiji Tanaka,et al.  CHIP is a chaperone‐dependent E3 ligase that ubiquitylates unfolded protein , 2001, EMBO reports.

[25]  D. Cyr,et al.  CHIP Is a U-box-dependent E3 Ubiquitin Ligase , 2001, The Journal of Biological Chemistry.

[26]  B. He,et al.  Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 Coactivator Recruitment by Activation Function 2* , 2001, The Journal of Biological Chemistry.

[27]  C. Patterson,et al.  Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling , 2001, Current Biology.

[28]  J. W. Thornton Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Foster,et al.  Hormone Status Selects for Spontaneous Somatic Androgen Receptor Variants That Demonstrate Specific Ligand and Cofactor Dependent Activities in Autochthonous Prostate Cancer* , 2001, The Journal of Biological Chemistry.

[30]  F. S. French,et al.  Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. , 2001, Cancer research.

[31]  J. Frydman,et al.  Molecular chaperones and the art of recognizing a lost cause , 2001, Nature Cell Biology.

[32]  J. Palvimo,et al.  Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. A. Kemppainen,et al.  FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor* , 2000, The Journal of Biological Chemistry.

[34]  Luis Moroder,et al.  Structure of TPR Domain–Peptide Complexes Critical Elements in the Assembly of the Hsp70–Hsp90 Multichaperone Machine , 2000, Cell.

[35]  K. Horwitz,et al.  The N-terminal Region of the Human Progesterone A-receptor , 2000, The Journal of Biological Chemistry.

[36]  P. Connell,et al.  The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins , 2000, Nature Cell Biology.

[37]  D. Cyr,et al.  The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation , 2000, Nature Cell Biology.

[38]  H. Gronemeyer,et al.  Activation Function 2 in the Human Androgen Receptor Ligand Binding Domain Mediates Interdomain Communication with the NH2-terminal Domain* , 1999, The Journal of Biological Chemistry.

[39]  P. Connell,et al.  Identification of CHIP, a Novel Tetratricopeptide Repeat-Containing Protein That Interacts with Heat Shock Proteins and Negatively Regulates Chaperone Functions , 1999, Molecular and Cellular Biology.

[40]  I. Baskakov,et al.  Trimethylamine N-Oxide-induced Cooperative Folding of an Intrinsically Unfolded Transcription-activating Fragment of Human Glucocorticoid Receptor* , 1999, The Journal of Biological Chemistry.

[41]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[42]  Desok Kim,et al.  Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. , 1998, Cancer research.

[43]  C. Glass,et al.  Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. , 1998, Genes & development.

[44]  R J Fletterick,et al.  Structure and specificity of nuclear receptor-coactivator interactions. , 1998, Genes & development.

[45]  H. Gronemeyer,et al.  The coactivator TIF2 contains three nuclear receptor‐binding motifs and mediates transactivation through CBP binding‐dependent and ‐independent pathways , 1998, The EMBO journal.

[46]  J. A. Kemppainen,et al.  Intermolecular NH2-/Carboxyl-terminal Interactions in Androgen Receptor Dimerization Revealed by Mutations That Cause Androgen Insensitivity* , 1998, The Journal of Biological Chemistry.

[47]  Timothy A. J. Haystead,et al.  The Amino-terminal Domain of Heat Shock Protein 90 (hsp90) That Binds Geldanamycin Is an ATP/ADP Switch Domain That Regulates hsp90 Conformation* , 1997, The Journal of Biological Chemistry.

[48]  A. Levine,et al.  Induced α Helix in the VP16 Activation Domain upon Binding to a Human TAF , 1997 .

[49]  J. Gustafsson,et al.  Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  B. Segnitz,et al.  The Function of Steroid Hormone Receptors Is Inhibited by the hsp90-specific Compound Geldanamycin* , 1997, The Journal of Biological Chemistry.

[51]  Christopher K. Glass,et al.  The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function , 1997, Nature.

[52]  David M. Heery,et al.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.

[53]  D. Robins,et al.  Hsp90 Regulates Androgen Receptor Hormone Binding Affinity in Vivo* , 1996, The Journal of Biological Chemistry.

[54]  R. Rimerman,et al.  Mutational analysis of the hsp70-interacting protein Hip , 1996, Molecular and cellular biology.

[55]  N. Chamberlain,et al.  Delineation of Two Distinct Type 1 Activation Functions in the Androgen Receptor Amino-terminal Domain* , 1996, The Journal of Biological Chemistry.

[56]  L. Nazareth,et al.  Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway* , 1996, The Journal of Biological Chemistry.

[57]  F. Hartl,et al.  Hip, a novel cochaperone involved in the eukaryotic hsc70/hsp40 reaction cycle , 1995, Cell.

[58]  R. Matusik,et al.  Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[59]  B. Katzenellenbogen,et al.  Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. , 1994, The Journal of biological chemistry.

[60]  F. S. French,et al.  Molecular Biological Aspects of the Human Androgen Receptor Relating to Disease , 1994 .

[61]  P. Chambon,et al.  Modulation of transcriptional activation by ligand‐dependent phosphorylation of the human oestrogen receptor A/B region. , 1993, The EMBO journal.

[62]  E. Wilson,et al.  Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. , 1992, The Journal of biological chemistry.

[63]  F. S. French,et al.  Transcriptional activation and nuclear targeting signals of the human androgen receptor. , 1991, The Journal of biological chemistry.

[64]  Mitsuhiro Yanagida,et al.  Snap helix with knob and hole: Essential repeats in S. pombe nuclear protein nuc2 + , 1990, Cell.

[65]  Mark S. Boguski,et al.  A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis , 1990, Cell.

[66]  F. S. French,et al.  The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. , 1988, Molecular endocrinology.

[67]  R. Evans,et al.  Primary structure and expression of a functional human glucocorticoid receptor cDNA , 1985, Nature.